Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic …

MA Nauck, MM Heimesaat, KAI Behle… - The Journal of …, 2002 - academic.oup.com
Glucagon-like peptide 1 (GLP-1) and analogues are being evaluated as a new therapeutic
principle for the treatment of type 2 diabetes. GLP-1 suppresses glucagon secretion, which …
被引用次数：757 相关文章

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic …

MA Nauck, MM Heimesaat, K Behle… - The Journal of …, 2002 - pubmed.ncbi.nlm.nih.gov
Glucagon-like peptide 1 (GLP-1) and analogues are being evaluated as a new therapeutic
principle for the treatment of type 2 diabetes. GLP-1 suppresses glucagon secretion, which …

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic …

MA Nauck, MM Heimesaat, K Behle… - The Journal of …, 2002 - europepmc.org
Glucagon-like peptide 1 (GLP-1) and analogues are being evaluated as a new therapeutic
principle for the treatment of type 2 diabetes. GLP-1 suppresses glucagon secretion, which …

[引用][C] Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped …

MA NAUCK, MM HEIMESAAT… - The Journal of …, 2002 - pascal-francis.inist.fr
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive
functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp …

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic …

MA Nauck, MM Heimesaat, K Behle, JJ Holst… - 2002 - publications.goettingen-research …
Glucagon-like peptide 1 (GLP-1) and analogues are being evaluated as a new therapeutic
principle for the treatment of type 2 diabetes. GLP-1 suppresses glucagon secretion, which …

[引用][C] Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped …

N MA - J Clin Endocrinol Metab, 2002 - cir.nii.ac.jp
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive
functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp …
[PDF] researchgate.net

[PDF][PDF] Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped …

The Journal of Clinical Endocrinology & Metabolism - researchgate.net
Study design All participants were studied in random order on two occasions: 1)
hyperinsulinemic, stepwise hypoglycemic clamp experiment (22, 24) with glucose plateaus …
[PDF] archive.org

[PDF][PDF] Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped …

The Journal of Clinical Endocrinology & Metabolism - scholar.archive.org
Study design All participants were studied in random order on two occasions: 1)
hyperinsulinemic, stepwise hypoglycemic clamp experiment (22, 24) with glucose plateaus …

[引用][C] Effects of glucagon-like peptide 1 on counterregulatory hormone responses, congestive functions, and insulin secretion during hyperinsulinemic, stepped …

N MA - J Clin Endocrinol Metab, 2002 - cir.nii.ac.jp
Effects of glucagon-like peptide 1 on counterregulatory hormone responses, congestive
functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp …